SCHEMBL6068320

SCHEMBL6068320

Fc1ccc2ncsc2c1Cl

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCNE1 P24864 1/20 0.37
CDK2 P24941 1/20 0.37
CDK5 Q00535 1/20 0.37
CDK5R1 Q15078 1/20 0.37
ALDH1A1 P00352 1/20 0.33
HSD17B10 Q99714 1/20 0.33
AXL P30530 1/20 0.33
MKNK1 Q9BUB5 1/20 0.33
MKNK2 Q9HBH9 1/20 0.33
NPC1 O15118 6/20 0.32
RAB9A P51151 6/20 0.32
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
APP P05067 1/20 0.32
P2RX7 Q99572 1/20 0.32
PKLR P30613 1/20 0.32
DYRK1A Q13627 1/20 0.32
PTPN11 Q06124 1/20 0.31
CSNK2A1 P68400 1/20 0.31
GRM4 Q14833 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2069128 0.79 ALDH1A1 (0.35) ALDH1A1HSD17B10AXLMKNK1MKNK2
SCHEMBL21631702 0.76 ALDH1A1 (0.33) ALDH1A1HSD17B10AXLMKNK1MKNK2
SCHEMBL30002369 0.76 P2RX7 (0.36) CDK2ALDH1A1HSD17B10NPC1RAB9A
SCHEMBL29309229 0.76 ALDH1A1 (0.33) ALDH1A1HSD17B10AXLMKNK1MKNK2
SCHEMBL659694 0.76 ALDH1A1 (0.33) ALDH1A1HSD17B10NPC1RAB9ATGFBR1
SCHEMBL6788818 0.76 DYRK1A (0.39) ALDH1A1HSD17B10AXLMKNK1MKNK2
SCHEMBL659590 0.72 NPC1 (0.31) ALDH1A1HSD17B10NPC1RAB9AMEN1
SCHEMBL30744846 0.71 NPC1 (0.44) NPC1RAB9AMEN1KMT2APKLR
SCHEMBL18876142 0.68 ALDH1A1 (0.35) ALDH1A1
SCHEMBL9195380 0.68 NR4A2 (0.40) ALDH1A1NPC1RAB9AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7091227-B2 Benzothiazole derivatives ABBOTT GMBH & CO. KG (DE) 2006-08-15 US disclosed
US-20030153568-A1 Benzothiazole derivatives BASF AKTIENGESELLSCHAFT LUDWIGSHAFEN, GERMANY 2003-08-14 US disclosed
CN-1422262-A 2-benzothiazolyl urea derivatives and their use as protein kinase inhibitors ABBOTT GMBH & CO KG (DE) 2003-06-04 CN disclosed
EP-1254123-A1 2-BENZOTHIAZOLYL UREA DERIVATIVES AND THEIR USE AS PROTEIN KINASE INHIBITORS Abbott GmbH & Co. KG (DE) 2002-11-06 EP disclosed
WO-2001057008-A1 2-BENZOTHIAZOLYL UREA DERIVATIVES AND THEIR USE AS PROTEIN KINASE INHIBITORS ABBOTT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG & COMPANY KOMMANDITGESELLSCHAFT (DE) 2001-08-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030153568-A1 Benzothiazole derivatives TK1, FLT1, CDK1 CCNE1 26/4885CDK2 12/4885CDK5 50/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.